@article{ef95c43049d74998bd2d6e298f29b0ec,
title = "Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer",
keywords = "CASTRATION-RESISTANT, THERAPY, ODM-201, ARADES, SAFETY, 3121 General medicine, internal medicine and other clinical medicine",
author = "{ARASENS Trial Investigators} and Smith, {Matthew R.} and Maha Hussain and Fred Saad and Karim Fizazi and Sternberg, {Cora N.} and Crawford, {E. David} and Evgeny Kopyltsov and Park, {Chandler H.} and Boris Alekseev and Alvaro Montesa-Pino and Dingwei Ye and Francis Parnis and Felipe Cruz and Tammela, {Teuvo L. J.} and Hiroyoshi Suzuki and Tapio Utriainen and Cheng Fu and Motohide Uemura and Mendez-Vidal, {Maria J.} and Maughan, {Benjamin L.} and Heikki Joensuu and Silke Thiele and Rui Li and Iris Kuss and Bertrand Tombal",
year = "2022",
month = mar,
day = "24",
doi = "10.1056/NEJMoa2119115",
language = "English",
volume = "386",
pages = "1132--1142",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "12",
}